Insiders Zentiva S.A.

Equities

End-of-day quote Bucharest S.E. Other stock markets 23:00:00 13/05/2024 BST			5-day change	1st Jan Change
3.18 ^RON	-2.45%		-4.79%	+8.90%

04-01	Biocon Limited, Through Zentiva, Receives Approval from, U.K., for its Complex Formulation Liraglutide (gSaxenda®) in 6mg/ml Solution	CI
02-29	Zentiva S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

STEFFEN SALTOFTE APPOINTED AS CEO OF ZENTIVA	19/04/23	AQ
Zentiva SA : Eric Jullien appointed Head of Industrial Affairs and Development for Zentiva	14/09/11	PU

No results for this search